[go: up one dir, main page]

Cascio et al., 1985 - Google Patents

N-Phenylpiperazine derivatives with hypocholesterolemic activity

Cascio et al., 1985

Document ID
8365449168834145884
Author
Cascio G
Manghisi E
Porta R
Fregnan G
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

A series of new 4-(4-phenyl-l-piperazinyl)-l-(4-fluorophenyl)-2-(acyloxy)-l-butanones and 4- aryl-5-[oi-(4-aryl-lpiperazinyl) alkyl]-l, 3-dioxol-2-ones were synthesized and tested preliminarily for hypolipemic activity. Plasma cholesterol-lowering activity in normalrats was …
Continue reading at pubs.acs.org (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in position 1,2, e.g. lipoic acid

Similar Documents

Publication Publication Date Title
Emmanuel‐Giota et al. Synthesis and biological evaluation of several 3‐(coumarin‐4‐yl) tetrahydroisoxazole and 3‐(coumarin‐4‐yl) dihydropyrazole derivatives
US4840951A (en) Novel naphthalene derivative
US5646149A (en) Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
JP2703408B2 (en) 1,4-benzothiazepine derivatives
DE3608032A1 (en) NEW, SULFURIZED 5-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EP0106565B1 (en) Leukotriene antagonists, their production, and compositions containing them
JPH0641455B2 (en) Pyridazinone derivative
PT674626E (en) SELECTIVE INHIBITION COMPOUNDS OF AROMATASE.
US4866058A (en) Method for control of hyperlipidemia
EP0388309B1 (en) 1H,3H,7-pyrrolo [1,2-c] thiazolecarboxamides, their preparation and pharmaceutical compositions containing them
FR2595695A1 (en) N - ((((2-HYDROXYHYL) PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
CZ280084B6 (en) Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and pharmaceutical preparation in which said derivatives are comprised
Cascio et al. N-Phenylpiperazine derivatives with hypocholesterolemic activity
Campiani et al. New pyrrolobenzothiazepine derivatives as molecular probes of the ‘peripheral-type’benzodiazepine receptor (PBR) binding site
BE1007245A3 (en) Di-substituted derivatives of n, n'-ditrimethoxybenzoyle piperazine, a process for their preparation and therapeutic compositions containing.
EP0115979A1 (en) Derivatives of 1H,3H-pyrrolo(1,2-c)thiazole, their preparation and pharmaceuticals containing them
FR2601011A1 (en) NEW AGONISTIC TRICYCLIC DERIVATIVES OF CHOLINERGIC RECEPTORS AND MEDICAMENTS CONTAINING SAME
CA1209995A (en) Process for preparing n-substituted nicotinamide 1-oxide compounds and the salts thereof; compounds and salts thus obtained
HU192653B (en) Process for the production of imidazo /1,2-c/pyrimidines, as well as of therapeutic preparations containing these compounds as agent
US4946963A (en) Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
CA1298294C (en) Pyrrole derivatives, their preparation and their pharmaceutical compositions therein
US4105764A (en) 4,5-Dihydro-5-oxopyrazolo[1,5-A]quinazoline-3-carboxamides
JPS58210088A (en) Antiatherosclerotic azafurochromone
EP0002401B1 (en) Derivatives of naphthalene, process for their preparation and their therapeutic application
US5192761A (en) 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-diones, pharmaceutical compositions